{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:23:25Z","timestamp":1794248605723,"version":"4.9.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,21]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>A macular hole (MH) secondary to macular telangiectasia (MacTel) type 2 is generally considered a poor surgical candidate when internal limiting membrane (ILM) peeling is performed. Due to the scarcity of studies on MH in MacTel type 2 patients, the number of published studies exploring the surgical outcomes of these patients is limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>In this case report, we report a case with MacTel type 2 with bilateral MHs and had a good visual prognosis after surgical treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>A 66-year-old woman was referred to our hospital for macular abnormalities in the right eye. The best-corrected visual acuity (BCVA) was 20\/32 in the right eye and 20\/16 in the left eye at the initial examination. Ophthalmic examination revealed decreased retinal transparency temporal to the fovea in both eyes, cystoid spaces at the macula of the right eye by optical coherence tomography, telangiectasia temporal to the fovea, and fluorescent leakage temporal to the fovea by fluorescein angiography in both eyes and the patient was diagnosed with MacTel type 2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Since there was no tendency toward vision loss, the patient was followed up without any treatment. Four years later, the BCVA of the right eye had decreased to 20\/50, and outer retinal layer atrophy at the macula had progressed, so the patient underwent cataract surgery, pars plana vitrectomy (PPV), and fluid-air exchange. Seven months after the initial surgery, an MH was formed in the right eye. Second surgery including PPV, ILM peeling, and sulfur hexafluoride gas tamponade were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Postoperatively, the MH was closed, and the BCVA improved to 20\/32 at 1 year, and 20\/20 at 12 years after the surgery, respectively. Twelve years after the initial visit, an MH appeared in the left eye, and the BCVA decreased to 20\/50, so cataract surgery, PPV with inverted ILM-flap technique, and sulfur hexafluoride gas tamponade were performed in the left eye. Postoperatively, the MH was closed with no recurrence for longer than 2 years after surgery, and the BCVA improved to 20\/16. Microperimetry performed after the surgery showed decreased retinal sensitivity consistent with areas of retinal atrophy in both eyes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>We experienced a case of bilateral MHs associated with MacTel type 2. The right eye underwent PPV with ILM peeling and the left eye underwent PPV with an inverted ILM flap technique, both eyes had good visual prognosis. Imaging modalities and microperimetry can provide valuable information on the associated anatomical and functional changes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000041847","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T01:05:58Z","timestamp":1743037558000},"page":"e41847","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["A case of macular telangiectasia type 2 with bilateral macular holes: Imaging features and surgical management"],"prefix":"10.1097","volume":"104","author":[{"given":"Yuta","family":"Usami","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan"},{"name":"Department of Ophthalmology, Gamagori Municipal Hospital, Gamagori, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eka Rahmawati","family":"Wahyuningsih","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kuwayama","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuntaro","family":"Ogura","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayo","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aki","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9173-0839","authenticated-orcid":false,"given":"Yoshio","family":"Hirano","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Ogura","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Yasukawa","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261109","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ajo.2010.11.019","article-title":"Monthly ranibizumab for nonproliferative macular telangiectasia type 2: a 12-month prospective study.","volume":"151","author":"Charbel Issa","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"R2-20261109","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/1120672118769527","article-title":"Macular telangiectasia type II with pachychoroid spectrum of macular disorders.","volume":"29","author":"Kumar","year":"2019","journal-title":"Eur J Ophthalmol"},{"key":"R3-20261109","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00417-020-04989-x","article-title":"Morphological features of macular telangiectasia type 2 in Japanese patients.","volume":"259","author":"Shinkai","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R4-20261109","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ajo.2010.02.013","article-title":"The prevalence of macular telangiectasia type 2 in the Beaver Dam eye study.","volume":"150","author":"Klein","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"R5-20261109","doi-asserted-by":"crossref","first-page":"100261","DOI":"10.1016\/j.xops.2022.100261","article-title":"Macular telangiectasia type 2: a classification system using multimodal imaging MacTel project report number 10.","volume":"3","author":"Chew","year":"2022","journal-title":"Ophthalmol Sci"},{"key":"R6-20261109","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4103\/0974-9233.65501","article-title":"Idiopathic juxtafoveolar retinal telangiectasis: a current review.","volume":"17","author":"Nowilaty","year":"2010","journal-title":"Middle East Afr J Ophthalmol"},{"key":"R7-20261109","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.2147\/OPTH.S373538","article-title":"Macular telangiectasia type 2: a comprehensive review.","volume":"16","author":"Kedarisetti","year":"2022","journal-title":"Clin Ophthalmol"},{"key":"R8-20261109","article-title":"Macular telangiectasia type 2: case report and clinical review","author":"Mangum","journal-title":"CRO J"},{"key":"R9-20261109","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3341\/kjo.2015.29.3.155","article-title":"Demographic features of idiopathic macular telangiectasia in Korean patients.","volume":"29","author":"Kim","year":"2015","journal-title":"Korean J Ophthalmol"},{"key":"R10-20261109","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.eye.6703003","article-title":"Macular full-thickness and lamellar holes in association with type 2 idiopathic macular telangiectasia.","volume":"23","author":"Charbel Issa","year":"2009","journal-title":"Eye (Lond)"},{"key":"R11-20261109","doi-asserted-by":"crossref","first-page":"NP81","DOI":"10.1177\/1120672119886177","article-title":"Inverted internal limiting membrane-flap technique to treat a full-thickness macular hole complicating idiopathic macular telangiectasia type 2.","volume":"31","author":"Sborgia","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"R12-20261109","first-page":"8884638","article-title":"Surgical outcomes in macular telangiectasia type 2-related macular holes: a report on four patients.","volume":"2020","author":"Ahmad","year":"2020","journal-title":"Case Rep Ophthalmol Med"},{"key":"R13-20261109","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00417-005-0057-9","article-title":"Macular hole formation associated with idiopathic parafoveal telangiectasia.","volume":"244","author":"Olson","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R14-20261109","doi-asserted-by":"crossref","first-page":"e27078","DOI":"10.1097\/MD.0000000000027078","article-title":"Two years outcomes of treating full-thickness macula hole associated with idiopathic macular telangiectasia type 2 by internal limiting membrane inverted flap technique: case reports.","volume":"100","author":"Nishiyama","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"R15-20261109","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.oret.2019.11.017","article-title":"Efficacy of macular hole surgery in patients with idiopathic macular telangiectasia type 2.","volume":"4","author":"Miller","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"R16-20261109","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00006982-200002000-00028","article-title":"Histopathologic study of presumed parafiveal telangiectasis.","volume":"20","author":"Gass","year":"2000","journal-title":"Retina"},{"key":"R17-20261109","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/01.iae.0000246678.93495.2f","article-title":"Full-thickness macular hole formation in idiopathic parafoveal telangiectasis.","volume":"27","author":"Koizumi","year":"2007","journal-title":"Retina"},{"key":"R18-20261109","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/IAE.0000000000000009","article-title":"Outcomes of macular hole surgeries for macular telangiectasia type 2.","volume":"34","author":"Karth","year":"2014","journal-title":"Retina"},{"key":"R19-20261109","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1001\/archopht.1991.01080050068031","article-title":"Vitreous surgery for idiopathic macular holes. Results of a pilot study.","volume":"109","author":"Kelly","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"R20-20261109","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ophtha.2023.08.025","article-title":"Surgical management of full-thickness macular holes in macular telangiectasia type 2: a global multicenter study.","volume":"131","author":"Park","year":"2024","journal-title":"Ophthalmology"},{"key":"R21-20261109","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41598-021-04739-x","article-title":"Effect of inverted internal limiting membrane flap technique on small-medium size macular holes.","volume":"12","author":"Yamada","year":"2022","journal-title":"Sci Rep"},{"key":"R22-20261109","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s003470050156","article-title":"Removal of the internal limiting membrane in macular holes. Clinical and morphological findings.","volume":"94","author":"Eckardt","year":"1997","journal-title":"Ophthalmologe"},{"key":"R23-20261109","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1159\/000534873","article-title":"Inverted internal limiting membrane flap versus internal limiting membrane peeling for <400 \u03bcm macular hole: a meta-analysis and systematic review.","volume":"66","author":"Li","year":"2023","journal-title":"Ophthalmic Res"},{"key":"R24-20261109","doi-asserted-by":"crossref","first-page":"837","DOI":"10.18240\/ijo.2023.06.01","article-title":"How internal limiting membrane peeling revolutionized macular surgery in the last three decades.","volume":"16","author":"Wiedemann","year":"2023","journal-title":"Int J Ophthalmol"},{"key":"R25-20261109","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/IAE.0b013e31815e98c0","article-title":"Parafoveal telangiectasia (PFT) has been associated with changes in macular architecture and macular holes (lamellar and full thickness).","volume":"28","author":"Rishi","year":"2008","journal-title":"Retina"},{"key":"R26-20261109","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.ophtha.2010.02.011","article-title":"Inverted internal limiting membrane flap technique for large macular holes.","volume":"117","author":"Michalewska","year":"2010","journal-title":"Ophthalmology"},{"key":"R27-20261109","doi-asserted-by":"crossref","first-page":"20035","DOI":"10.1038\/s41598-021-99509-0","article-title":"Contractility of temporal inverted internal limiting membrane flap after vitrectomy for macular hole.","volume":"11","author":"Hirata","year":"2021","journal-title":"Sci Rep"},{"key":"R28-20261109","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1167\/iovs.17-21756","article-title":"The role of inverted internal limiting membrane flap in macular hole closure.","volume":"58","author":"Shiode","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R29-20261109","first-page":"1","article-title":"Surgery for full-thickness macular hole in patients with idiopathic macular telangiectasia type 2.","volume":"41 Online","author":"Gregori","year":"2010","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"R30-20261109","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/eye.2010.233","article-title":"Evolution and management of macular hole secondary to type 2 idiopathic macular telangiectasia.","volume":"25","author":"Shukla","year":"2011","journal-title":"Eye (Lond)"},{"key":"R31-20261109","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4103\/tjo.TJO-D-22-00154","article-title":"Clinical features of macular telangiectasia type 2 and comparison of staging system in Taiwanese patients.","volume":"13","author":"Chen","year":"2023","journal-title":"Taiwan J Ophthalmol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000041847","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:00:55Z","timestamp":1794247255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000041847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041847","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,21]]}}}